Kallum Titchmarsh
Stock Analyst at Morgan Stanley
(0.32)
# 4,324
Out of 5,090 analysts
20
Total ratings
25%
Success rate
-15.79%
Average return
Main Sectors:
Stocks Rated by Kallum Titchmarsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Initiates: Equal-Weight | $285 | $280.23 | +1.70% | 1 | Dec 2, 2025 | |
| WAT Waters | Initiates: Equal-Weight | $423 | $394.81 | +7.14% | 1 | Dec 2, 2025 | |
| MTD Mettler-Toledo International | Initiates: Equal-Weight | $1,550 | $1,414.86 | +9.55% | 1 | Dec 2, 2025 | |
| INSP Inspire Medical Systems | Downgrades: Equal-Weight | $105 → $130 | $136.81 | -4.98% | 7 | Dec 2, 2025 | |
| DHR Danaher | Initiates: Overweight | $270 | $226.25 | +19.34% | 1 | Dec 2, 2025 | |
| A Agilent Technologies | Initiates: Overweight | $180 | $145.49 | +23.72% | 1 | Dec 2, 2025 | |
| PEN Penumbra | Maintains: Equal-Weight | $260 → $266 | $300.66 | -11.53% | 8 | Jul 31, 2025 |
West Pharmaceutical Services
Dec 2, 2025
Initiates: Equal-Weight
Price Target: $285
Current: $280.23
Upside: +1.70%
Waters
Dec 2, 2025
Initiates: Equal-Weight
Price Target: $423
Current: $394.81
Upside: +7.14%
Mettler-Toledo International
Dec 2, 2025
Initiates: Equal-Weight
Price Target: $1,550
Current: $1,414.86
Upside: +9.55%
Inspire Medical Systems
Dec 2, 2025
Downgrades: Equal-Weight
Price Target: $105 → $130
Current: $136.81
Upside: -4.98%
Danaher
Dec 2, 2025
Initiates: Overweight
Price Target: $270
Current: $226.25
Upside: +19.34%
Agilent Technologies
Dec 2, 2025
Initiates: Overweight
Price Target: $180
Current: $145.49
Upside: +23.72%
Penumbra
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $260 → $266
Current: $300.66
Upside: -11.53%